Lonza | LONN - Sales Revenues

Stock Price
508.60
Daily Change
5.60 1.11%
Monthly
1.99%
Yearly
0.71%
Q2 Forecast
499.29

Lonza reported CHF3.58B in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
Almirall EUR 547.63M 12.83M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
BASF EUR 14.03B 300M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Beiersdorf EUR 2.31B 40M Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Demant DKK 6.26B 810M Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Geberit CHF 715.4M 67.1M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GN Store Nord DKK 4.68B 720M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Sika AG CHF 5.52B 151.5M Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
Solvay EUR 995M 45M Dec/2025
UCB EUR 4.25B 764M Dec/2025